Report Detail
Global Anticoagulants Market Growth 2019-2024
- RnM2983012 |
- 19 February, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of anticoagulants used to treat AF, and the revenue in 2016 is 13118 M USD.
Europe region is the largest supplier of anticoagulants, with a production market share nearly 56.40% in 2016. North America is the second largest supplier of anticoagulants, enjoying production market share nearly 26.35% in 2016.
According to this study, over the next five years the Anticoagulants market will register a 8.8% CAGR in terms of revenue, the global market size will reach US$ 1230 million by 2024, from US$ 740 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoagulants business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulants market by product type, application, key manufacturers and key regions and countries.
This study considers the Anticoagulants value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
VTE
ACS/MI
AF
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anticoagulants consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anticoagulants market by identifying its various subsegments.
Focuses on the key global Anticoagulants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anticoagulants with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anticoagulants submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Anticoagulants Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Anticoagulants Consumption 2014-2024
- 2.1.2 Anticoagulants Consumption CAGR by Region
- 2.2 Anticoagulants Segment by Type
- 2.2.1 Platelet aggregation inhibitors (PAI)
- 2.2.2 Low-molecular-weight Heparin (LMWH)
- 2.2.3 Direct thrombin inhibitor (DTI)
- 2.2.4 Direct factor Xa inhibitors (DFXa)
- 2.2.5 Vitamin K antagonists (VKA)
- 2.2.6 Others
- 2.3 Anticoagulants Consumption by Type
- 2.3.1 Global Anticoagulants Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Anticoagulants Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Anticoagulants Sale Price by Type (2014-2019)
- 2.4 Anticoagulants Segment by Application
- 2.4.1 VTE
- 2.4.2 ACS/MI
- 2.4.3 AF
- 2.4.4 Other
- 2.5 Anticoagulants Consumption by Application
- 2.5.1 Global Anticoagulants Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Anticoagulants Value and Market Share by Application (2014-2019)
- 2.5.3 Global Anticoagulants Sale Price by Application (2014-2019)
3 Global Anticoagulants by Players
- 3.1 Global Anticoagulants Sales Market Share by Players
- 3.1.1 Global Anticoagulants Sales by Players (2017-2019)
- 3.1.2 Global Anticoagulants Sales Market Share by Players (2017-2019)
- 3.2 Global Anticoagulants Revenue Market Share by Players
- 3.2.1 Global Anticoagulants Revenue by Players (2017-2019)
- 3.2.2 Global Anticoagulants Revenue Market Share by Players (2017-2019)
- 3.3 Global Anticoagulants Sale Price by Players
- 3.4 Global Anticoagulants Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Anticoagulants Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Anticoagulants Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Anticoagulants by Regions
- 4.1 Anticoagulants by Regions
- 4.1.1 Global Anticoagulants Consumption by Regions
- 4.1.2 Global Anticoagulants Value by Regions
- 4.2 Americas Anticoagulants Consumption Growth
- 4.3 APAC Anticoagulants Consumption Growth
- 4.4 Europe Anticoagulants Consumption Growth
- 4.5 Middle East & Africa Anticoagulants Consumption Growth
5 Americas
- 5.1 Americas Anticoagulants Consumption by Countries
- 5.1.1 Americas Anticoagulants Consumption by Countries (2014-2019)
- 5.1.2 Americas Anticoagulants Value by Countries (2014-2019)
- 5.2 Americas Anticoagulants Consumption by Type
- 5.3 Americas Anticoagulants Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Anticoagulants Consumption by Countries
- 6.1.1 APAC Anticoagulants Consumption by Countries (2014-2019)
- 6.1.2 APAC Anticoagulants Value by Countries (2014-2019)
- 6.2 APAC Anticoagulants Consumption by Type
- 6.3 APAC Anticoagulants Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Anticoagulants by Countries
- 7.1.1 Europe Anticoagulants Consumption by Countries (2014-2019)
- 7.1.2 Europe Anticoagulants Value by Countries (2014-2019)
- 7.2 Europe Anticoagulants Consumption by Type
- 7.3 Europe Anticoagulants Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Anticoagulants by Countries
- 8.1.1 Middle East & Africa Anticoagulants Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Anticoagulants Value by Countries (2014-2019)
- 8.2 Middle East & Africa Anticoagulants Consumption by Type
- 8.3 Middle East & Africa Anticoagulants Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Anticoagulants Distributors
- 10.3 Anticoagulants Customer
11 Global Anticoagulants Market Forecast
- 11.1 Global Anticoagulants Consumption Forecast (2019-2024)
- 11.2 Global Anticoagulants Forecast by Regions
- 11.2.1 Global Anticoagulants Forecast by Regions (2019-2024)
- 11.2.2 Global Anticoagulants Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Anticoagulants Forecast by Type
- 11.8 Global Anticoagulants Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi
- 12.1.1 Company Details
- 12.1.2 Anticoagulants Product Offered
- 12.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi News
- 12.2 Bayer
- 12.2.1 Company Details
- 12.2.2 Anticoagulants Product Offered
- 12.2.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer News
- 12.3 Boehringer Ingelheim
- 12.3.1 Company Details
- 12.3.2 Anticoagulants Product Offered
- 12.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Boehringer Ingelheim News
- 12.4 Johnson & Johnson
- 12.4.1 Company Details
- 12.4.2 Anticoagulants Product Offered
- 12.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Johnson & Johnson News
- 12.5 Genentech (Roche)
- 12.5.1 Company Details
- 12.5.2 Anticoagulants Product Offered
- 12.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Genentech (Roche) News
- 12.6 AstraZeneca
- 12.6.1 Company Details
- 12.6.2 Anticoagulants Product Offered
- 12.6.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 AstraZeneca News
- 12.7 Bristol-Myers Squibb
- 12.7.1 Company Details
- 12.7.2 Anticoagulants Product Offered
- 12.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Bristol-Myers Squibb News
- 12.8 Aspen
- 12.8.1 Company Details
- 12.8.2 Anticoagulants Product Offered
- 12.8.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Aspen News
- 12.9 Lilly
- 12.9.1 Company Details
- 12.9.2 Anticoagulants Product Offered
- 12.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Lilly News
- 12.10 Otsuka
- 12.10.1 Company Details
- 12.10.2 Anticoagulants Product Offered
- 12.10.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Otsuka News
- 12.11 Pfizer
- 12.12 Daiichi Sankyo
- 12.13 The Medicines Company
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Anticoagulants . Industry analysis & Market Report on Anticoagulants is a syndicated market report, published as Global Anticoagulants Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Anticoagulants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
